REG - GAIL (India) Ltd - Final Results & Dividend declaration for FY25
Outcome of the Board Meeting of GAIL (India) Limited- Integrated Filing (Financials) for the quarter and FY ended 31st March, 2025 and recommendation of payment of Final Dividend for FY 2024-25
Pursuant to the SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31st December, 2024, please find enclosed herewith the Integrated Filing (Financial) for the quarter and FY ended 31st March, 2025 as per SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 containing:
1. Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and FY ended 31st March, 2025 along with Independent Auditors' Report with unmodified opinion(s) of Joint Statutory Auditors of the Company in accordance with Regulation 33, 52(1) and 52 (4) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, approved by the Board of Directors of the Company at its meeting held today i.e. on 13th May, 2025.
2. Statement indicating no Deviation or Variation in the use of proceeds of issue of listed non-convertible unsecured debentures in accordance with Regulation 52(7) & 52(7A) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
3. Format for disclosing outstanding default on loans and debt securities.
4. Security cover available in accordance with Regulation 54(2) & (3) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
The Board of the Company has recommended the payment of Final Dividend @ 10% (Re. 1.00 per equity share) on the paid-up equity share capital of the Company, subject to approval of shareholders in the ensuing Annual General Meeting. The record date for payment of Final Dividend would be intimated in due course.
The Board meeting commenced at 11:30 A.M. and concluded at 02:15 P.M.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ACSUOSKRVSUVARR
